The Role of Remdesivir in South Africa: Preventing COVID-19 Deaths Through Increasing Intensive Care Unit Capacity

Countries such as South Africa have limited intensive care unit (ICU) capacity to handle the expected number of patients with COVID-19 requiring ICU care. Remdesivir can prevent deaths in countries such as South Africa by decreasing the number of days people spend in ICU, therefore freeing up ICU be...

Full description

Saved in:
Bibliographic Details
Published in:Clinical infectious diseases 2021-05, Vol.72 (9), p.1642-1644
Main Authors: Nichols, Brooke E, Jamieson, Lise, Zhang, Sabrina R C, Rao, Gabriella A, Silal, Sheetal, Pulliam, Juliet R C, Sanne, Ian, Meyer-Rath, Gesine
Format: Article
Language:English
Subjects:
Adenosine Monophosphate - analogs & derivatives
Alanine - analogs & derivatives
Brief Reports
COVID-19 Drug Treatment
Humans
Intensive Care Units
SARS-CoV-2
South Africa - epidemiology
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c3322-e61b7efa74dca64b40a450dcadb09cb3d65f359b90e5cb22b1a50b3c9dc449d23
cites cdi_FETCH-LOGICAL-c3322-e61b7efa74dca64b40a450dcadb09cb3d65f359b90e5cb22b1a50b3c9dc449d23
container_end_page 1644
container_issue 9
container_start_page 1642
container_title Clinical infectious diseases
container_volume 72
creator Nichols, Brooke E
Jamieson, Lise
Zhang, Sabrina R C
Rao, Gabriella A
Silal, Sheetal
Pulliam, Juliet R C
Sanne, Ian
Meyer-Rath, Gesine
description Countries such as South Africa have limited intensive care unit (ICU) capacity to handle the expected number of patients with COVID-19 requiring ICU care. Remdesivir can prevent deaths in countries such as South Africa by decreasing the number of days people spend in ICU, therefore freeing up ICU bed capacity.
doi_str_mv 10.1093/cid/ciaa937
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7454458</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2421122871</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3322-e61b7efa74dca64b40a450dcadb09cb3d65f359b90e5cb22b1a50b3c9dc449d23</originalsourceid><addsrcrecordid>eNpVkc1r3DAQxUVoyFd76r3oWChu9WlbOQTCJmkXAgnpplchyeO1ilfaSvZC_vsoZBvawzAP5sebYR5CHyn5Soni35zvShmjeHOATqjkTVVLRd8VTWRbiZa3x-g059-EUNoSeYSOOatZ2whxgtJqAPwQR8Cxxw-w6SD7nU_YB_wzztOAL_vknTnH9wl2ECYf1nhx92t5VVGFr8BMQ8arIcV5PeBlcAlMfkGWYYJQnAAvTAL8GPxU1NY4Pz29R4e9GTN82Pcz9HhzvVr8qG7vvi8Xl7eV45yxCmpqG-hNIzpnamEFMUKSojtLlLO8q2XPpbKKgHSWMUuNJJY71TkhVMf4Gbp49d3OdgOdK9cnM-pt8huTnnQ0Xv8_CX7Q67jTjZBCyLYYfN4bpPhnhjzpjc8OxtEEiHPWTDBKWXkkLeiXV9SlmHOC_m0NJfolJV1S0vuUCv3p38ve2L-x8GeokpBO</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2421122871</pqid></control><display><type>article</type><title>The Role of Remdesivir in South Africa: Preventing COVID-19 Deaths Through Increasing Intensive Care Unit Capacity</title><source>Oxford Journals Online</source><creator>Nichols, Brooke E ; Jamieson, Lise ; Zhang, Sabrina R C ; Rao, Gabriella A ; Silal, Sheetal ; Pulliam, Juliet R C ; Sanne, Ian ; Meyer-Rath, Gesine</creator><creatorcontrib>Nichols, Brooke E ; Jamieson, Lise ; Zhang, Sabrina R C ; Rao, Gabriella A ; Silal, Sheetal ; Pulliam, Juliet R C ; Sanne, Ian ; Meyer-Rath, Gesine</creatorcontrib><description>Countries such as South Africa have limited intensive care unit (ICU) capacity to handle the expected number of patients with COVID-19 requiring ICU care. Remdesivir can prevent deaths in countries such as South Africa by decreasing the number of days people spend in ICU, therefore freeing up ICU bed capacity.</description><identifier>ISSN: 1058-4838</identifier><identifier>ISSN: 1537-6591</identifier><identifier>EISSN: 1537-6591</identifier><identifier>DOI: 10.1093/cid/ciaa937</identifier><identifier>PMID: 32628744</identifier><language>eng</language><publisher>United States: Oxford University Press</publisher><subject>Adenosine Monophosphate - analogs &amp; derivatives ; Alanine - analogs &amp; derivatives ; Brief Reports ; COVID-19 Drug Treatment ; Humans ; Intensive Care Units ; SARS-CoV-2 ; South Africa - epidemiology</subject><ispartof>Clinical infectious diseases, 2021-05, Vol.72 (9), p.1642-1644</ispartof><rights>The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America.</rights><rights>The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. 2020</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3322-e61b7efa74dca64b40a450dcadb09cb3d65f359b90e5cb22b1a50b3c9dc449d23</citedby><cites>FETCH-LOGICAL-c3322-e61b7efa74dca64b40a450dcadb09cb3d65f359b90e5cb22b1a50b3c9dc449d23</cites><orcidid>0000-0003-4682-4999</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32628744$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Nichols, Brooke E</creatorcontrib><creatorcontrib>Jamieson, Lise</creatorcontrib><creatorcontrib>Zhang, Sabrina R C</creatorcontrib><creatorcontrib>Rao, Gabriella A</creatorcontrib><creatorcontrib>Silal, Sheetal</creatorcontrib><creatorcontrib>Pulliam, Juliet R C</creatorcontrib><creatorcontrib>Sanne, Ian</creatorcontrib><creatorcontrib>Meyer-Rath, Gesine</creatorcontrib><title>The Role of Remdesivir in South Africa: Preventing COVID-19 Deaths Through Increasing Intensive Care Unit Capacity</title><title>Clinical infectious diseases</title><addtitle>Clin Infect Dis</addtitle><description>Countries such as South Africa have limited intensive care unit (ICU) capacity to handle the expected number of patients with COVID-19 requiring ICU care. Remdesivir can prevent deaths in countries such as South Africa by decreasing the number of days people spend in ICU, therefore freeing up ICU bed capacity.</description><subject>Adenosine Monophosphate - analogs &amp; derivatives</subject><subject>Alanine - analogs &amp; derivatives</subject><subject>Brief Reports</subject><subject>COVID-19 Drug Treatment</subject><subject>Humans</subject><subject>Intensive Care Units</subject><subject>SARS-CoV-2</subject><subject>South Africa - epidemiology</subject><issn>1058-4838</issn><issn>1537-6591</issn><issn>1537-6591</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNpVkc1r3DAQxUVoyFd76r3oWChu9WlbOQTCJmkXAgnpplchyeO1ilfaSvZC_vsoZBvawzAP5sebYR5CHyn5Soni35zvShmjeHOATqjkTVVLRd8VTWRbiZa3x-g059-EUNoSeYSOOatZ2whxgtJqAPwQR8Cxxw-w6SD7nU_YB_wzztOAL_vknTnH9wl2ECYf1nhx92t5VVGFr8BMQ8arIcV5PeBlcAlMfkGWYYJQnAAvTAL8GPxU1NY4Pz29R4e9GTN82Pcz9HhzvVr8qG7vvi8Xl7eV45yxCmpqG-hNIzpnamEFMUKSojtLlLO8q2XPpbKKgHSWMUuNJJY71TkhVMf4Gbp49d3OdgOdK9cnM-pt8huTnnQ0Xv8_CX7Q67jTjZBCyLYYfN4bpPhnhjzpjc8OxtEEiHPWTDBKWXkkLeiXV9SlmHOC_m0NJfolJV1S0vuUCv3p38ve2L-x8GeokpBO</recordid><startdate>20210504</startdate><enddate>20210504</enddate><creator>Nichols, Brooke E</creator><creator>Jamieson, Lise</creator><creator>Zhang, Sabrina R C</creator><creator>Rao, Gabriella A</creator><creator>Silal, Sheetal</creator><creator>Pulliam, Juliet R C</creator><creator>Sanne, Ian</creator><creator>Meyer-Rath, Gesine</creator><general>Oxford University Press</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-4682-4999</orcidid></search><sort><creationdate>20210504</creationdate><title>The Role of Remdesivir in South Africa: Preventing COVID-19 Deaths Through Increasing Intensive Care Unit Capacity</title><author>Nichols, Brooke E ; Jamieson, Lise ; Zhang, Sabrina R C ; Rao, Gabriella A ; Silal, Sheetal ; Pulliam, Juliet R C ; Sanne, Ian ; Meyer-Rath, Gesine</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3322-e61b7efa74dca64b40a450dcadb09cb3d65f359b90e5cb22b1a50b3c9dc449d23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Adenosine Monophosphate - analogs &amp; derivatives</topic><topic>Alanine - analogs &amp; derivatives</topic><topic>Brief Reports</topic><topic>COVID-19 Drug Treatment</topic><topic>Humans</topic><topic>Intensive Care Units</topic><topic>SARS-CoV-2</topic><topic>South Africa - epidemiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Nichols, Brooke E</creatorcontrib><creatorcontrib>Jamieson, Lise</creatorcontrib><creatorcontrib>Zhang, Sabrina R C</creatorcontrib><creatorcontrib>Rao, Gabriella A</creatorcontrib><creatorcontrib>Silal, Sheetal</creatorcontrib><creatorcontrib>Pulliam, Juliet R C</creatorcontrib><creatorcontrib>Sanne, Ian</creatorcontrib><creatorcontrib>Meyer-Rath, Gesine</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Clinical infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Nichols, Brooke E</au><au>Jamieson, Lise</au><au>Zhang, Sabrina R C</au><au>Rao, Gabriella A</au><au>Silal, Sheetal</au><au>Pulliam, Juliet R C</au><au>Sanne, Ian</au><au>Meyer-Rath, Gesine</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Role of Remdesivir in South Africa: Preventing COVID-19 Deaths Through Increasing Intensive Care Unit Capacity</atitle><jtitle>Clinical infectious diseases</jtitle><addtitle>Clin Infect Dis</addtitle><date>2021-05-04</date><risdate>2021</risdate><volume>72</volume><issue>9</issue><spage>1642</spage><epage>1644</epage><pages>1642-1644</pages><issn>1058-4838</issn><issn>1537-6591</issn><eissn>1537-6591</eissn><abstract>Countries such as South Africa have limited intensive care unit (ICU) capacity to handle the expected number of patients with COVID-19 requiring ICU care. Remdesivir can prevent deaths in countries such as South Africa by decreasing the number of days people spend in ICU, therefore freeing up ICU bed capacity.</abstract><cop>United States</cop><pub>Oxford University Press</pub><pmid>32628744</pmid><doi>10.1093/cid/ciaa937</doi><tpages>3</tpages><orcidid>https://orcid.org/0000-0003-4682-4999</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1058-4838
ispartof Clinical infectious diseases, 2021-05, Vol.72 (9), p.1642-1644
issn 1058-4838
1537-6591
1537-6591
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7454458
source Oxford Journals Online
subjects Adenosine Monophosphate - analogs & derivatives
Alanine - analogs & derivatives
Brief Reports
COVID-19 Drug Treatment
Humans
Intensive Care Units
SARS-CoV-2
South Africa - epidemiology
title The Role of Remdesivir in South Africa: Preventing COVID-19 Deaths Through Increasing Intensive Care Unit Capacity
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T03%3A05%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Role%20of%20Remdesivir%20in%20South%20Africa:%20Preventing%20COVID-19%20Deaths%20Through%20Increasing%20Intensive%20Care%20Unit%20Capacity&rft.jtitle=Clinical%20infectious%20diseases&rft.au=Nichols,%20Brooke%20E&rft.date=2021-05-04&rft.volume=72&rft.issue=9&rft.spage=1642&rft.epage=1644&rft.pages=1642-1644&rft.issn=1058-4838&rft.eissn=1537-6591&rft_id=info:doi/10.1093/cid/ciaa937&rft_dat=%3Cproquest_pubme%3E2421122871%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3322-e61b7efa74dca64b40a450dcadb09cb3d65f359b90e5cb22b1a50b3c9dc449d23%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2421122871&rft_id=info:pmid/32628744&rfr_iscdi=true